BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24647969)

  • 21. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
    Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
    PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline.
    Yang SF; Tsai CH; Chang YC
    J Oral Pathol Med; 2008 Apr; 37(4):206-10. PubMed ID: 18221324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline.
    Jeng JH; Wang YJ; Chiang BL; Lee PH; Chan CP; Ho YS; Wang TM; Lee JJ; Hahn LJ; Chang MC
    Carcinogenesis; 2003 Aug; 24(8):1301-15. PubMed ID: 12807728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis.
    Tsai CH; Yang SF; Lee SS; Chang YC
    Oral Dis; 2009 May; 15(4):281-6. PubMed ID: 19388153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth of oral and skin fibroblasts from patients with oral submucous fibrosis.
    van Wyk CW; Olivier A; Hoal-van Helden EG; Grobler-Rabie AF
    J Oral Pathol Med; 1995 Sep; 24(8):349-53. PubMed ID: 7500290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
    Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
    J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline.
    Ho YC; Yang SF; Lee SS; Chang YC
    J Formos Med Assoc; 2017 Jun; 116(6):484-487. PubMed ID: 28365254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
    Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
    J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral submucous fibrosis: review on aetiology and pathogenesis.
    Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
    Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arecoline suppresses HaCaT cell proliferation through cell cycle regulatory molecules.
    Zhou ZS; Li M; Gao F; Peng JY; Xiao HB; Dai LX; Lin SR; Zhang R; Jin LY
    Oncol Rep; 2013 Jun; 29(6):2438-44. PubMed ID: 23525646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
    Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
    Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
    Yu CC; Liao YW; Yu CH; Chang YC
    J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of protease-activated receptor-1 expression in human buccal fibroblasts stimulated with arecoline.
    Tsai CH; Lee SS; Huang FM; Chang YC
    Head Neck; 2013 Sep; 35(9):1314-8. PubMed ID: 22965839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arecoline suppresses epithelial cell viability by upregulating tropomyosin-1 through the transforming growth factor-β/Smad pathway.
    Li L; Gu L; Yao Z; Wang Y; Tang Z; Wu X
    Pharm Biol; 2020 Nov; 58(1):1244-1251. PubMed ID: 33332205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of arecoline on the differentiation of myofibroblasts of oral mucosa].
    Li X; Ling TY; Gao YJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jul; 42(7):423-7. PubMed ID: 17961364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
    Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
    Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
    Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
    Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.